Wolverine Trading
HAE icon

Wolverine Trading’s Haemonetics HAE Stock Holding History

Wolverine Trading’s Portfolio HAE Stock Details HAE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		$491K Buy
10,200
+7,000
+219% +$433K ﹤0.01% 3739
2025
Q2 		$236K Sell
3,200
-3,200
-50% -$212K ﹤0.01% 3728
2025
Q1 		$404K Sell
6,400
-27,900
-81% -$1.9M ﹤0.01% 3204
2024
Q4 		$2.63M Buy
+34,300
New +$2.76M ﹤0.01% 1743
2021
Q3 		– Sell
-58,300
Closed -$3.89M – 6519
2021
Q2 		$3.89M Buy
+58,300
New +$4.13M 0.01% 1369
2020
Q3 		– Sell
-3,300
Closed -$290K – 4775
2020
Q2 		$290K Buy
+3,300
New +$333K ﹤0.01% 3379
2018
Q4 		– Sell
-3,100
Closed -$355K – 4783
2018
Q3 		$355K Buy
+3,100
New +$321K ﹤0.01% 3521

Other funds holding HAE

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
RRAM
River Road Asset Management Louisville, Kentucky $8.99B AUM 12.83% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Wolverine Trading's HAE Position: Q2 2025 in Review

Wolverine Trading sold out of Haemonetics (HAE) in Q2 2025, closing a stake of 3,573 shares — an estimated $237K sold.

Wolverine Trading first reported a position in HAE in Q1 2018 and held it in 9 quarters. The position peaked at $1.14M in Q2 2021. 298 funds tracked by Wall St. Rank hold HAE as of Q2 2025.

  • Wolverine Trading reported no remaining Haemonetics position as of Q2 2025 after selling out during the quarter.
  • Wolverine Trading sold 3,573 Haemonetics shares in Q2 2025, an estimated $237K.
  • Wolverine Trading first reported a position in Haemonetics in Q1 2018 and held it in 9 quarters.
  • Wolverine Trading's Haemonetics position peaked at $1.14M in Q2 2021.
  • 298 funds tracked by Wall St. Rank held Haemonetics as of Q2 2025.

Based on Wolverine Trading's 13F filing for Q2 2025, filed 18 Aug 2025.